Vaxxinity Inc. (NASDAQ:VAXX) went down by -7.18% from its latest closing price compared to the recent 1-year high of $22.77. The company’s stock price has collected -17.80% of loss in the last five trading sessions.
Is It Worth Investing in Vaxxinity Inc. (NASDAQ :VAXX) Right Now?
Opinions of the stock are interesting as 2 analysts out of 3 who provided ratings for Vaxxinity Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $15.00, which is $13.06 above the current price. VAXX currently public float of 52.35M and currently shorts hold a 0.65% ratio of that float. Today, the average trading volume of VAXX was 1.02M shares.
VAXX’s Market Performance
VAXX stocks went down by -17.80% for the week, with a monthly drop of -56.11% and a quarterly performance of -59.24%. The volatility ratio for the week stands at 12.61% while the volatility levels for the past 30 days are set at 14.78% for Vaxxinity Inc. The simple moving average for the period of the last 20 days is -42.71% for VAXX stocks with a simple moving average of -68.18% for the last 200 days.
VAXX Trading at -51.55% from the 50-Day Moving Average
After a stumble in the market that brought VAXX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.48% of loss for the given period.
Volatility was left at 14.78%, however, over the last 30 days, the volatility rate increased by 12.61%, as shares sank -56.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -53.25% lower at present.
During the last 5 trading sessions, VAXX fell by -17.80%, in comparison to the 20-day moving average, which settled at $3.26. In addition, Vaxxinity Inc. saw -65.42% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at VAXX starting from Reese Lou, who purchase 100,000 shares at the price of $1.99 back on Jun 16. After this action, Reese Lou now owns 51,737,344 shares of Vaxxinity Inc., valued at $199,290 using the latest closing price.
UNITED BIOMEDICAL INC, the 10% Owner of Vaxxinity Inc., purchase 100,000 shares at $1.99 during a trade that took place back on Jun 16, which means that UNITED BIOMEDICAL INC is holding 51,737,344 shares at $199,290 based on the most recent closing price.
Stock Fundamentals for VAXX
Current profitability levels for the company are sitting at:
- -189507.58 for the present operating margin
- -4504.55 for the gross margin
The net margin for Vaxxinity Inc. stands at -207840.91.
The liquidity ratio also appears to be rather interesting for investors as it stands at 5.61.